Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by HighSkies2019on Mar 09, 2022 10:29am
239 Views
Post# 34499226

Yesterday !!!

Yesterday !!!Therma Bright 20-million-share private placement 2022-03-08 20:23 ET - Private Placement The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement announced on Feb. 16, 2022. Number of shares: 20 million common shares Purchase price: 30 cents per common share Warrants: 20 million share purchase warrants to purchase 20 million shares Warrant exercise price: 37.5 cents until Feb. 18, 2027 Number of placees: two placees Insider/pro group participation: none Finder's fee: H.C. Wainwright & Co. LLC, $480,000 and 1.6 million finder's warrants, with each finder's warrant entitling the holder to acquire one common share at 37.5 cents until Feb. 18, 2027 Note that in certain circumstances the exchange may later extend the expiry date of the warrants, if they are less than the maximum permitted term.
<< Previous
Bullboard Posts
Next >>